1 / 50

Paediatric blood transfusion

Paediatric blood transfusion. Dr. Chitra Rajeswari T Dr. Lokesh Kashyap. www.anaesthesia.co.in anaesthesia.co.in@gmail.com. Why to transfuse blood. Basic physiological function is to ensure adequate oxygenation of the tissues Physiology of oxygen transport. Hypoxic hypoxia.

hye
Download Presentation

Paediatric blood transfusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Paediatric blood transfusion Dr. Chitra Rajeswari T Dr. Lokesh Kashyap www.anaesthesia.co.inanaesthesia.co.in@gmail.com

  2. Why to transfuse blood • Basic physiological function is to ensure adequate oxygenation of the tissues • Physiology of oxygen transport

  3. Hypoxic hypoxia Anaemic hypoxia Histotoxic hypoxia Stagnant hypoxia

  4. Anaemic hypoxia

  5. Oxygen delivery • DaO2 =Cardiac output X CaO2 [oxygen content] • Oxygen content [Hb saturation X 1.34 X Hb conc] + 0.003 X PO2 Amount of oxygen carried by 100 ml of blood

  6. Fetal hemoglobin Cardiac reserve Increased metabolism

  7. Fetal hemoglobin • HbF – 70-80% of full term and 97% of premature infants’ total hemoglobin at birth

  8. Fetal hemoglobin • Shorter life span of 90 days (HbA- 120 days) • HbF interacts poorly with 2,3,DPG • P50 with HbF is 19 mmHg • P50 with HbA is 27 mmHg • Leftward shift of ODC

  9. ODC

  10. Hemoglobin for equivalent oxygen delivery Motoyama et al. 1990

  11. 6 months- 6 years 12 7-13 years 13 6 months- 6 years 12 7- 13 years 13

  12. Preoperative hemoglobin • At the time of nadir • Term infant with Hb < 9 g/dl • Preterm infant <7 g/dl • Haemoglobin levels that are adequate for the older patients may be suboptimal in the younger infant

  13. Fetal hemoglobin Cardiac reserve Increased metabolism

  14. Adult vs children - cardiac reserve • Children have a higher cardiac output to blood volume ratio than adults Sandra et al. Pediatric anesthesia 2005

  15. Adult vs children - cardiac reserve • The neonatal myocardium operates at near maximum level of performance as a baseline • The newborn’s heart may be unable to compensate for a decreased oxygen carrying capacity by increasing cardiac output • The neonatal myocardium will also suffer a greater degree of decompensation when exposed to decreased oxygen delivery

  16. Metabolism • Oxygen consumption

  17. When to transfuse blood?

  18. MABL • MABL = Starting – Target hematocrit • Blood loss more than this target value then RBC cell transfusion should be initiated • 65 ml of packed RBC [Hct 70%] = 150 ml of whole blood [Hct 30%] • 0.5 ml of PRBC for each ml of blood loss beyond the MABL • 1 ml/kg PRBC raises the hematocrit by 1.5% X EBV Starting hematocrit

  19. May benefit from higher hematocrit • Preterm and term infants • Cyanotic congenital heart disease • Large ventilation/ perfusion mismatch • High metabolic demand • Respiratory failure

  20. Guidelines for perioperative management of anemia

  21. Guidelines contd… • In an elective setting, anemia should be evaluated and treated,surgery may be postponed for a month or longer • Cumulative record of blood loss should be kept for critically ill infants and loss replaced when it exceeds 10% of blood volume

  22. Guidelines contd… • In an emergency setting, anesthesia administered with extreme caution • Maintain high PaO2 • Adequate cardiac output • Adequate intravascular volume • Avoid factors increasing oxygen consumption • Avoid leftward shift of ODC

  23. Guidelines contd… • Oxygen extraction ratio as hematocrit drops to 15%, OER increases from 38 to 60% • Central venous Po2 • Decline of pVo2 is the most sensitive indicator of anemia • Normal => 38 mm Hg Holland et al. 1987

  24. Pediatric transfusions –guidelines • Platelet transfusions • platelet count less than 50000 in acute bleeding • Less than 1 lakh for intracranial and Subarachnoid or extra corporeal circulation procedures • 5 mL/kg - 10 mL/kg causes a rise of platelets of 50 to 100 * 109/L • Fresh frozen plasma • aPTT or PT > 1.5 times normal • 10-15 ml/kg • Cryoprecipitate • Fibrinogen 100 mg/dl • 1 unit /10 kg BW raises plasma fibrinogen by 50 mg/dl

  25. Transfusion reactions • Acute transfusion reactions ( < 24 hours) • Febrile nonhemolytic reaction • Urticarial/allergic reaction • Acute hemolytic reaction • Bacterial contamination and sepsis • Fluid overload • Anaphylaxis • TRALI • Delayed transfusion reaction • Infection • Delayed hemolytic reaction • Post transfusion purpura • Graft Vs host disease • Iron overload

  26. TRALI • TRALI • Acute hypoxemia • Non-cardiogenic pulmonary edema • During or after transfusion • Leading cause of transfusion-related mortality in 2003 – FDA, TRALI conference • Underdiagnosis & underreporting

  27. Incidence • All plasma-containing blood & blood components • 1/5,000 blood & blood component • 1/2,000 plasma-containing component • 1/7,900 units of FFP • 1/432 units of whole blood derived platelets

  28. Pathophysiology • Leukocyte antibodies • Biologically active substance • Lipids & cytokines • Neutrophil priming activity • Leukocyte Antibodies • Neutrophil in pulmonary capillary → pulmonary damage & capillary leak • Antibody to donor leukocyte • Ab to HLA I, II, granulocyte, monocyte, IgA

  29. Management • Supportive • Stop transfusion if timely recognition • Oxygen and ventilatory support as employed in ARDS • Avoid blood from multiparous female donors

  30. Immunologic • Transfusion related graft vs host disease • Lymphocytes in transfused blood component proliferate and cause host tissue destruction • Immunocompromised patient • Premature infants • Children with cancer or severe systemic illness • Acute blood loss • Cardiopulmonary bypass Prevented by irradiated blood

  31. Pediatric transfusions - neonates • Neonates have some specific considerations with respect to anesthesia and blood products. • Major hemolytic reaction (ABO) occurs less frequently in neonates compared with older children and adults. • For the first 3–4 months of life, infants are unable to form alloantibodies to RBC antigens. • After 4 months of age, hemolytic reactions become a potential factor

  32. Massive blood transfusion

  33. Definition • Loss of one or more circulating blood volume in 24 hour • 50% blood volume in 3 hours • Loss occurring at the rate of 2-3 ml/kg/min

  34. Problems of massive transfusion • Hypocalcemia • Hyperkalemia • Hypomagnesemia • Hypothermia • Volume overload • Dilutional coagulopathy • Acid base changes • Shift of ODC curve • Microaggregate delivery • TRALI

  35. Hypocalcemia • Degree of ionized hypocalcemia depends upon • Blood product transfused • Rate • Hepatic blood flow • Hepatic function

  36. Hypocalcemia • Degree of ionized hypocalcemia depends upon • Blood product transfused • Rate • Hepatic blood flow • Hepatic function FFP > 1 ml / kg / min Decreased ability to metabolise by neonate

  37. Hypocalcemia Myocardial depression Inhalational agents Decreased ability to metabolise by neonate

  38. Prevention of hypocalcemia • Rate should be < 1 ml / kg / min • If more than > 1 ml / kg / min calcium should also be transfused • Calcium infusion • Calcium chloride 5-10 mg/kg • Calcium gluconate 15-30 mg/kg • Frequent measurement of ionised calcium

  39. Hyperkalemia • Blood components with high potassium • Whole blood • Irradiated blood • Near the expiry date

  40. Prevention of hyperkalemia • Washing of erythrocytes • Newer blood (< 7 days) • Avoiding whole blood and prefer packed RBC

  41. Treatment • CaCl2 15-20 mg/kg • Calcium gluconate 45-60 mg/kg • 1-2 min intervals until the arrhythmia is resolved • Glucose and insulin • Hyperventilation • Albuterol • kayexalate

  42. Hypomagnesemia • Result of citrate toxicity • Stabilizes the resting membrane potential • Life threatening arrhythmia that dose not respond to exogenous calcium therapy needs magnesium sulphate • 25-50 mg/kg followed by 30-60 mg/kg/24 hours

  43. Acid-base changes • RBC metabloism can elevate the dissolved CO2 to 180-210 mmHg • Anaerobic metabolism increases the lactic acid content • Initial transient combined respiratory and metabolic acidosis • Citrate metabolism leads to metabolic alkalosis

  44. Hypothermia • Shift to left of ODC curve – decreased oxygen delivery • Apnea • Hypoglycemia • Decreased drug metabolism • Increased oxygen consumption • Coagulopathy

  45. Coagulopathy • Massive blood transfusion leads to thrombocytopenia • 40%, 20% and 10% of starting platelet count is seen after 1st, 2nd and 3rd blood volume loss • Dilution and loss of clotting factors • Clotting factor deficiency should be anticipated after one blood volume loss

  46. Recombinant factor VIIa • Retrospective review of use of factor 7a in children undergoing major neurosurgical procedures experiencing massive uncontrollable hemorrhage • Useful adjunct to control life threatening bleeding,but more extensive research is needed Uhring et al Ped crit care med, 2007

  47. Mechanism of action

  48. Blood Conservation • Preoperative Autologous Donation • Acute Normovolemic Hemodilution • Intraoperative Blood Salvage • Preoperative Erythropoietin • Positioning • Hypotensive anaesthesia • Pharmacological enhancement of hemostasis • Artificial blood www.anaesthesia.co.inanaesthesia.co.in@gmail.com

More Related